Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 10, 2020
0
Date of Patent
November 28, 2023
0
Patent Application Number
16925980
0
Patent Citations
‌
US Patent 9505839 Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof
0
‌
US Patent 9815898 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 9815901 Treatment of cancer using a CD123 chimeric antigen receptor
0
‌
US Patent 9834605 Antibodies to human programmed death receptor PD-1
0
‌
US Patent 9884913 Antibody molecules to TIM-3 and uses thereof
0
‌
US Patent 9908936 Antibody molecules to LAG-3 and uses thereof
0
‌
US Patent 9944645 Imidazotriazines and imidazopyrimidines as kinase inhibitors
0
‌
US Patent 9988452 Antibody molecules to PD-L1 and uses thereof
0
‌
US Patent 10005832 Method for treating a disease originated from receptor activation by EREG and TGFα
0
‌
US Patent 10253086 CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
0
•••
Patent Inventor Names
Hwai Wen Chang
0
Arlene Helen Sharpe
0
Gordon James Freeman
0
Jennifer Marie Mataraza
0
Catherine Anne Sabatos-Peyton
0
Walter A. Blattler
0
Gerhard Johann Frey
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11827704
0
Patent Primary Examiner
‌
Jessica H Roark
0
CPC Code
‌
G01N 33/566
0
‌
G01N 33/57484
0
‌
G01N 33/6854
0
‌
C07K 16/2896
0
‌
C07K 16/2818
0
‌
C07K 16/28
0
‌
C07K 16/2827
0

Find more entities like US Patent 11827704 Antibody molecules to PD-1 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.